---
Free space for your campaign:
Order

Welcome to licensed pharmacies in Poland:

Non-prescription medicines delivery across Europe.

Frequently ordered: potency boosters (sildenafil OTC), quit smoking aids.

Kobieta 64 (Anonymous, 188.146.164.) Warszawa 17 months ago

Is Pregabalin 50 mg safe for ventricular arrhythmia and cardiac ischemia considering other medications (Bisocard, Clatra, Atoris, Acard)?
51.00 zł

I have ventricular arrhythmia and ischemia, my psychiatrist prescribed me pregabalin 50mg to calm down, is this drug really safe for heart disease? I also take bisocard 2.5mg, clatra 20mg, atoris 10mg, acard 75mg

1 answer, 1 subscriber

* required field

You can drag the photo file here.

* required field

Notify of a new answer.
Other messages will not be sent.

Suggested Products

Space for your product

Your product would fit here?
Your product would fit here?

Set up a sponsored products campaign yourself:

Check
Anna Lewandowska

Anna Lewandowska Pharmacist, Editor

17 months ago

Pregabalin is not contraindicated in patients with heart disease, but it can cause dizziness, drowsiness or low blood pressure, which may be important in arrhythmia and ischemia. In combination with bisocard (beta-blocker), there is a risk of worsening bradycardia and hypotension. The decision to use pregabalin should be carefully monitored by a cardiologist and psychiatrist, with regular monitoring of cardiac parameters and blood pressure.

If you need more personalized advice, you can use teleconsultations here:

https://www.gdziepolek.pl/telekonsultacja/

The availability of Pregabalin in pharmacies in Polish can be checked at the following address:

https://www.gdziepolek.pl/produkty/89743/pregabalin-accord-kapsulki/apteki

Appreciate the answerer and highlight the question on the home page
User questions and answers that provide feedback about products are not verified for the purchase or use of the product. Companies often order anonymous comments to form positive opinions about their products, or negative ones about competitors. Therefore, be guided by the information in the pharmacists' responses in the first place.

Specialists